ArticleJournal of cellular and molecular medicine2018

MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.

Desheng Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.